243 related articles for article (PubMed ID: 24758588)
1. Long-term efficacy of infliximab for refractory ulcerative colitis: results from a single center experience.
Yamada S; Yoshino T; Matsuura M; Minami N; Toyonaga T; Honzawa Y; Tsuji Y; Nakase H
BMC Gastroenterol; 2014 Apr; 14():80. PubMed ID: 24758588
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of infliximab in treating patients with ulcerative colitis: experiences from a single medical center in southern China.
Zhou YL; Xie S; Wang P; Zhang T; Lin MY; Tan JS; Zhi FC; Jiang B; Chen Y
J Dig Dis; 2014 Sep; 15(9):483-90. PubMed ID: 24828856
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of infliximab treatment and predictors of response in 195 patients with ulcerative colitis: a hospital-based cohort study from Korea.
Seo H; Chang K; Lee SH; Song EM; Kim GU; Seo M; Lee HS; Hwang SW; Yang DH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yang SK; Park SH
Scand J Gastroenterol; 2017 Aug; 52(8):857-863. PubMed ID: 28502189
[TBL] [Abstract][Full Text] [Related]
4. Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis.
Armuzzi A; Pugliese D; Danese S; Rizzo G; Felice C; Marzo M; Andrisani G; Fiorino G; Nardone OM; De Vitis I; Papa A; Rapaccini GL; Guidi L
Inflamm Bowel Dis; 2014 Aug; 20(8):1368-74. PubMed ID: 24983979
[TBL] [Abstract][Full Text] [Related]
5. Extent of Early Clinical Response to Infliximab Predicts Long-term Treatment Success in Active Ulcerative Colitis.
Murthy SK; Greenberg GR; Croitoru K; Nguyen GC; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2015 Sep; 21(9):2090-6. PubMed ID: 26099066
[TBL] [Abstract][Full Text] [Related]
6. Short- and Long-Term Outcomes of Infliximab Treatment for Steroid-Refractory Ulcerative Colitis and Related Prognostic Factors: A Single-Center Retrospective Study.
Nasuno M; Miyakawa M; Tanaka H; Motoya S
Digestion; 2017; 95(1):67-71. PubMed ID: 28052276
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of infliximab in acute severe ulcerative colitis: a single-centre experience.
Halpin SJ; Hamlin PJ; Greer DP; Warren L; Ford AC
World J Gastroenterol; 2013 Feb; 19(7):1091-7. PubMed ID: 23467174
[TBL] [Abstract][Full Text] [Related]
8. Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience.
Laharie D; Filippi J; Roblin X; Nancey S; Chevaux JB; Hébuterne X; Flourié B; Capdepont M; Peyrin-Biroulet L
Aliment Pharmacol Ther; 2013 May; 37(10):998-1004. PubMed ID: 23521659
[TBL] [Abstract][Full Text] [Related]
9. Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis.
Jürgens M; Laubender RP; Hartl F; Weidinger M; Seiderer J; Wagner J; Wetzke M; Beigel F; Pfennig S; Stallhofer J; Schnitzler F; Tillack C; Lohse P; Göke B; Glas J; Ochsenkühn T; Brand S
Am J Gastroenterol; 2010 Aug; 105(8):1811-9. PubMed ID: 20197757
[TBL] [Abstract][Full Text] [Related]
10. Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis.
Nelson R; Liao C; Fichera A; Rubin DT; Pekow J
Inflamm Bowel Dis; 2014 Jan; 20(1):14-20. PubMed ID: 24297054
[TBL] [Abstract][Full Text] [Related]
11. Post-induction infliximab trough levels and disease activity in the clinical evolution of pediatric ulcerative colitis.
Moore H; Dolce P; Devas N; Baldassano R; Martinelli M
United European Gastroenterol J; 2020 May; 8(4):425-435. PubMed ID: 32213038
[TBL] [Abstract][Full Text] [Related]
12. Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis.
Rostholder E; Ahmed A; Cheifetz AS; Moss AC
Aliment Pharmacol Ther; 2012 Mar; 35(5):562-7. PubMed ID: 22239070
[TBL] [Abstract][Full Text] [Related]
13. A 10-year, single tertiary care center experience on the durability of infliximab in pediatric inflammatory bowel disease.
Vahabnezhad E; Rabizadeh S; Dubinsky MC
Inflamm Bowel Dis; 2014 Apr; 20(4):606-13. PubMed ID: 24552827
[TBL] [Abstract][Full Text] [Related]
14. High-dose infliximab for treatment of pediatric ulcerative colitis: a survey of clinical practice.
Nattiv R; Wojcicki JM; Garnett EA; Gupta N; Heyman MB
World J Gastroenterol; 2012 Mar; 18(11):1229-34. PubMed ID: 22468086
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects and colectomy rates in ulcerative colitis patients treated with infliximab: a Danish single center experience.
Teisner AS; Ainsworth MA; Brynskov J
Scand J Gastroenterol; 2010 Dec; 45(12):1457-63. PubMed ID: 20701434
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up study.
Iwasa R; Yamada A; Sono K; Furukawa R; Takeuchi K; Suzuki Y
BMC Gastroenterol; 2015 Aug; 15():103. PubMed ID: 26271624
[TBL] [Abstract][Full Text] [Related]
17. Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot Study.
Beswick L; Rosella O; Rosella G; Headon B; Sparrow MP; Gibson PR; van Langenberg DR
J Crohns Colitis; 2018 Feb; 12(3):289-297. PubMed ID: 29121178
[TBL] [Abstract][Full Text] [Related]
18. Short-Term and Long-Term Outcomes of Infliximab and Tacrolimus Treatment for Moderate to Severe Ulcerative Colitis: Retrospective Observational Study.
Otsuka T; Ooi M; Tobimatsu K; Wakahara C; Watanabe D; Adachi S; Yasutomi E; Yamairi H; Ku Y; Yoshida M; Hoshi N; Kodama Y
Kobe J Med Sci; 2018 Dec; 64(4):E140-E148. PubMed ID: 30728340
[TBL] [Abstract][Full Text] [Related]
19. Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study.
Sjöberg M; Walch A; Meshkat M; Gustavsson A; Järnerot G; Vogelsang H; Hertervig E; Novacek G; Friis-Liby I; Blomquist L; Angelberger S; Karlen P; Grännö C; Vilien M; Ström M; Verbaan H; Hellström PM; Dejaco C; Magnuson A; Halfvarson J; Reinisch W; Tysk C
Inflamm Bowel Dis; 2012 Feb; 18(2):212-8. PubMed ID: 21438096
[TBL] [Abstract][Full Text] [Related]
20. Predictors of early response to infliximab in patients with ulcerative colitis.
Ferrante M; Vermeire S; Katsanos KH; Noman M; Van Assche G; Schnitzler F; Arijs I; De Hertogh G; Hoffman I; Geboes JK; Rutgeerts P
Inflamm Bowel Dis; 2007 Feb; 13(2):123-8. PubMed ID: 17206703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
